Awakn Life Sciences Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$5.55M
Awakn Life Sciences General Information
Description
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling it to provide breakthrough therapeutics to addiction sufferers in desperate need.
Contact Information
Website
www.awaknlifesciences.comCorporate Office
- 217 Queen Street West
- Suite 301
- Toronto, Ontario M5V 0R2
- Canada
Corporate Office
- 217 Queen Street West
- Suite 301
- Toronto, Ontario M5V 0R2
- Canada
Awakn Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 27-May-2025 | $5.55M | Completed | Generating Revenue | ||
| 8. Secondary Transaction - Private | 16-Jan-2025 | Completed | Generating Revenue | |||
| 7. PIPE | 03-Apr-2024 | Completed | Generating Revenue | |||
| 6. PIPE | 14-Sep-2023 | Completed | Generating Revenue | |||
| 5. PIPE | 17-Nov-2022 | Completed | Generating Revenue | |||
| 4. PIPE | 22-Mar-2022 | Completed | Generating Revenue | |||
| 3. Reverse Merger | 23-Jun-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 08-Jun-2021 | $8.3M | $8.3M | Completed | Generating Revenue | |
| 1. Early Stage VC | 01-May-2021 | Completed | Generating Revenue |
Awakn Life Sciences Comparisons
Industry
Financing
Details
Awakn Life Sciences Competitors (5)
One of Awakn Life Sciences’s 5 competitors is AtaiBeckley, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AtaiBeckley | Formerly VC-backed | New York, NY | ||||
| Indivior | Corporate Backed or Acquired | North Chesterfield, VA | ||||
| Entheon Biomedical | Formerly Angel backed | Vancouver, Canada | ||||
| COMPASS Pathways | Formerly VC-backed | Altrincham, United Kingdom | ||||
| Alkermes | Formerly VC-backed | Dublin, Ireland |
Awakn Life Sciences Patents
Awakn Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022150525-A1 | Mdma in the treatment of alcohol use disorder | Inactive | 06-Jan-2021 | ||
| WO-2022150525-A9 | Mdma in the treatment of alcohol use disorder | Inactive | 06-Jan-2021 |
Awakn Life Sciences Signals
Awakn Life Sciences Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 1169082 B.C. | Corporation | Majority | ||
| Ambria Capital | Venture Capital | Minority | ||
| Canaccord Genuity | Investment Bank | Minority | ||
| Eight Capital (Toronto) | Asset Manager | Minority | ||
| Iter Investments | Venture Capital | Minority |
Awakn Life Sciences Acquisitions (3)
Awakn Life Sciences’s most recent deal was a Merger/Acquisition with Axonklinikken for . The deal was made on 04-Oct-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Axonklinikken | 04-Oct-2021 | Merger/Acquisition | Clinics/Outpatient Services | ||
| 1169082 B.C. | 08-Jun-2021 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) | ||
| Dr. Ben Sessa | 18-Jun-2020 | Merger/Acquisition | Clinics/Outpatient Services |
Awakn Life Sciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Services
Subindustry
Rank
Percentile
Awakn Life Sciences FAQs
-
When was Awakn Life Sciences founded?
Awakn Life Sciences was founded in 2020.
-
Where is Awakn Life Sciences headquartered?
Awakn Life Sciences is headquartered in Toronto, Canada.
-
What is the size of Awakn Life Sciences?
Awakn Life Sciences has 10 total employees.
-
What industry is Awakn Life Sciences in?
Awakn Life Sciences’s primary industry is Biotechnology.
-
Is Awakn Life Sciences a private or public company?
Awakn Life Sciences is a Private company.
-
What is the current valuation of Awakn Life Sciences?
The current valuation of Awakn Life Sciences is .
-
What is Awakn Life Sciences’s current revenue?
The current revenue for Awakn Life Sciences is .
-
How much funding has Awakn Life Sciences raised over time?
Awakn Life Sciences has raised $17.1M.
-
Who are Awakn Life Sciences’s investors?
1169082 B.C., Ambria Capital, Canaccord Genuity, Eight Capital (Toronto), and Iter Investments are 5 of 11 investors who have invested in Awakn Life Sciences.
-
Who are Awakn Life Sciences’s competitors?
AtaiBeckley, Indivior, Entheon Biomedical, COMPASS Pathways, and Alkermes are competitors of Awakn Life Sciences.
-
When was Awakn Life Sciences acquired?
Awakn Life Sciences was acquired on 27-May-2025.
-
Who acquired Awakn Life Sciences?
Awakn Life Sciences was acquired by Solvonis Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process